Prophylaxis in adults with haemophilia.

Prophylaxis in adults with haemophilia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Prophylaxis in adults with haemophilia. Abstract Text:

C R M Hay,C R M Hay,

The indications for and the efficacy of prophylaxis in adults with haemophilia remain controversial. It is unclear whether the benefits of secondary prophylaxis outweigh the costs, because adults with haemophilia usually already have established arthropathy. The objectives of secondary prophylaxis in this group are therefore more limited than the objectives of primary prophylaxis in children. It is also uncertain whether primary prophylaxis should stop or continue once adulthood is reached. Some individuals with near-normal joints may stop prophylaxis in early adulthood and then bleed infrequently. Others who stop prophylaxis begin to bleed frequently and suffer progressive arthropathy; these patients should probably have continued prophylaxis. There is no satisfactory method for selecting patients for continued prophylaxis. Adult prophylaxis is less well studied than prophylaxis in children. A few studies with a small number of patients suggest that adults treated with prophylaxis experienced fewer bleeding episodes, less pain and improved quality of life compared with those treated on demand. The mean annual cost of prophylaxis tends be substantially higher for adults than for children, largely owing to the high cost of clotting factor. Here we review the literature regarding the prophylactic treatment of adult patients with haemophilia A, including studies of the discontinuation of prophylaxis. These studies and others all show clinical benefit from prophylaxis in adulthood and suggest the possibility that optimized prophylaxis (e.g. tailoring an intermediate- or low-dose regimen in patients who bleed infrequently) may improve clinical outcome. The cost-effect argument is more difficult to sustain in adults compared with children; however, the cost of prophylaxis may be counterbalanced by indirect factors, such as days gained at work, reduced hospitalizations, reduced need for orthopaedic surgery and improved quality of life.

Prophylaxis in adults with haemophilia. Publishing Authors By Initials

CR Hay,CR Hay,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Prophylaxis in adults with haemophilia. Journal Published:

PUBLICATION TYPE: Review

Journal: Haemophilia : the official journal of the World Fe

VOLUME: 13 Suppl 2

Page Numbers: 10-5

Journal Abbreviation:

ISSN: 1351-8216

DAY: 9

MONTH: Sep

YEAR: 2007

Prophylaxis in adults with haemophilia. Information

Number of References: 17

LANGUAGE: eng

NlmUniqueID: 9442916

Prophylaxis in adults with haemophilia. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Prophylaxis in adults with haemophilia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Prophylaxis in adults with haemophilia.

AFFILIATION: University Department of Haematology, Manchester Royal Infirmary, Manchester, UK. Haemophilia@man.ac.uk

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Haemophilia

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Prophylaxis in adults with haemophilia Related Publications

• A synthetic maternal-effect selfish genetic element drives population replacement in Drosophila.
• Bacterial degradation of N,N-diethyl-m-toluamide (DEET): cloning and heterologous expression of DEET hydrolase.
• Calcium: a fundamental regulator of intracellular membrane fusion?
• Characteristics and zona binding ability of FRESH and cooled domestic cat epididymal spermatozoa.
• Chemically mediated competition between microbes and animals: microbes as consumers in food webs.
• Chronic fetal hypoglycemia inhibits the later steps of stimulus-secretion coupling in pancreatic beta-cells.
• Climatic similarity and biological exchange in the worldwide airline transportation network.
• Defining the global spatial limits of malaria transmission in 2005.
• Deletion 22q11: spectrum of associated disorders.
• Early postnatal nutritional requirements of the very preterm infant based on a presentation at the NICHD-AAP workshop on research in neonatology.
• Economic modeling and sensitivity analysis.
• Effect of hyperinsulinemia on amino acid utilization and oxidation independent of glucose metabolism in the ovine fetus.
• Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice.
• Evaluating the CSAPPA subscales as potential screening instruments for developmental coordination disorder.
• Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors.
• Global transport networks and infectious disease spread.
• How do changes in tumor matrix affect the outcome of virotherapy?
• Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus.
• Hypoglycemia in newborn infants: Features associated with adverse outcomes.
• Potential impacts of nonalgal materials on water-leaving Sun induced chlorophyll fluorescence signals in coastal waters.
• Predator release of the gastropod Cyphoma gibbosum increases predation on gorgonian corals.
• Prophylaxis in adults with haemophilia.
• Risk management: the top 10 mistakes dentists make.
• SNARE status regulates tether recruitment and function in homotypic COPII vesicle fusion.
• Sex differences in angiotensin II- induced hypertension.
• Skin toxicology.
• Stille coupling reactions in the synthesis of hypoxia-selective 3-alkyl-1,2,4-benzotriazine 1,4-dioxide anticancer agents.
• The Drosophila caspase Ice is important for many apoptotic cell deaths and for spermatid individualization, a nonapoptotic process.
• The gradual emergence of sex differences in aggression: alternative hypotheses.
• echinus, required for interommatidial cell sorting and cell death in the Drosophila pupal retina, encodes a protein with homology to ubiquitin-specific proteases.